Phibro Animal Health Corp. A Stock
A loss of -1.910% shows a downward development for Phibro Animal Health Corp. A.
The community is currently still undecided about Phibro Animal Health Corp. A with 1 Buy predictions and 1 Sell predictions.
As a result the target price of 33 € shows a slightly positive potential of 7.14% compared to the current price of 30.8 € for Phibro Animal Health Corp. A.
Pros and Cons of Phibro Animal Health Corp. A in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Phibro Animal Health Corp. A vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Phibro Animal Health Corp. A | -1.910% | 0.000% | 9.028% | 35.345% | -0.633% | 134.328% | 61.026% |
| Pacira Pharmaceuticals | -1.850% | 4.386% | 7.207% | 23.316% | 10.185% | -32.000% | -52.871% |
| Corcept Therapeutics Inc. | -0.480% | 18.155% | 22.758% | 57.410% | 40.099% | 237.324% | 426.374% |
| Supernus Pharmaceuticals | -1.060% | -7.882% | -10.526% | 15.432% | -13.023% | 30.769% | 66.964% |
Comments
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $50.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at Bank of America Corporation from $19.00 to $27.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for PAHC provided by MarketBeat
Phibro Animal Health Corporation (NASDAQ: PAHC) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $35.00 price target on the stock, up previously from $25.00.
Show more
Ratings data for PAHC provided by MarketBeat